The aim of this study is to produce short, individual reports on the current and future regulatory status and processes which are of relevance to the 19 HBM4EU Priority Substance Groups; and policy briefs for each of the nine substance groups in the first list of HBM4EU Priority Substance Groups. The 19 individual reports shall identify the current legislative status of the chemical substances under both EU chemicals legislation and any relevant multi-lateral agreements, including any ongoing or planned regulatory processes. Within these processes, the relevant entry points for the EEA to submit HBM4EU data will be highlighted. The nine policy briefs shall outline the progress made so far under the HBM4EU project by reviewing available human biomonitoring evidence, the ability of HBM4EU to produce new human biomonitoring evidence and where such human biomonitoring data can be used by policy makers and chemical risk managers.
Royal Society of Chemistry's report 'A Chemicals Strategy for a Sustainable Chemicals Revolution' published RPA is pleased to announce that the Royal Society of Chemistry (RSC) have published their report based upon work conducted […]
RPA to undertake a scoping study on international approaches to Japanese knotweed in the context of property sales RPA, Dr Daniel Jones from Advanced Invasives and Russell Hewitson, an Associate Professor at Northumbria Law School, have been commissioned […]